eNav Toolkit for Colorectal Cancer Screening

Recruiting in Palo Alto (17 mi)

Overseen bySarah Miller

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Icahn School of Medicine at Mount Sinai

Trial Summary

What is the purpose of this trial?The purpose of this research study is to evaluate the efficacy of a digital navigation tool, called the eNav to improve colorectal cancer screening uptake among patients treated at federally qualified health centers (FQHC)s. The digital navigation tool includes a website and text messaging support. The website includes information, motivational support, decisional support and cues to action (e.g., ability to request a CRC screening test). The eNav tool also includes text-messaging based navigation (e.g., reminders, instructions to complete the screening test).

Eligibility Criteria

This trial is for patients at federally qualified health centers who need colorectal cancer screening. There are no specific inclusion or exclusion criteria provided, so it's likely open to a broad range of individuals who require screening.

Inclusion Criteria

I can sign the consent form within a month of seeing my primary care doctor.

I am due for a colorectal cancer screening according to my medical records.

I am between 45 and 75 years old, eligible for colorectal cancer screening.

+4 more

Exclusion Criteria

I am unable to understand and give consent for treatment.

Participant Groups

The study is testing the eNav Toolkit—a digital tool with a website and text messaging support designed to increase colorectal cancer screening rates among patients. It provides information, motivation, decision aid, and reminders.

2Treatment groups

Experimental Treatment

Placebo Group

Group I: eNav interventionExperimental Treatment1 Intervention

Subjects assigned to this arm will receive a link to the eNav website.

Group II: Usual Care GroupPlacebo Group1 Intervention

Subjects assigned to this arm will not receive the link to the website and will receive standard clinical care.